deltatrials
Recruiting PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT07078331

Safety and Performance, and Dose, of OsteoAdapt DE in Localized Alveolar Ridge Augmentations (RESTORE)

A Prospective, Multi Center, Single-Blinded, Randomized, Controlled Study to Evaluate the Safety and Performance, and Dose, of OsteoAdapt DE in Localized Alveolar Ridge Augmentations for Defects Associated With Extraction Sockets - Feasibility Study

Sponsor: Theradaptive, Inc

Conditions Bone Graft Ridge Augmentation Tooth Extraction Site Healing
Interventions OsteoAdapt DE (0.8 mg) OsteoAdapt DE (2.0 mg) Xenograft Bone Graft
Updated 3 times since 2025 Last updated: Jan 30, 2026 Started: Jul 17, 2025 Primary completion: Apr 1, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07078331, this PHASE1/PHASE2 trial focuses on Bone Graft and Ridge Augmentation and remains actively recruiting participants. Sponsored by Theradaptive, Inc, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshotRecruiting~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshotRecruiting

Change History

3 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting PHASE1/PHASE2

  2. Sep 2025 — Feb 2026 [monthly]

    Recruiting PHASE1/PHASE2

  3. Aug 2025 — Sep 2025 [monthly]

    Recruiting PHASE1/PHASE2

    First recorded

Jul 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Theradaptive, Inc
Data source: Theradaptive, Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations